- The birth pangs of monoclonal antibody therapeutics: the failure and legacy of CentoxinLara Marks
Department of Primary Care and Public Health, King s College London, London, UK
MAbs 4:403-12. 2012..Indeed, Centocor's development of the drug brought it to the brink of bankruptcy. This article shows how many of the experiences learned with Centoxin paved the way for the current successes in therapeutic mAb development...